编号/登记号：
注册时间：
研究开始时间：
研究结束时间：
项目类型：
本院角色：
多中心研究：
招募状态：
试验分期：
研究疾病/适应症：
研究类型：
研究单位：
[1]Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
[2]ALPHA Recherche Clinique,Quebec, Canada, Qc G3K 2P8
[3]1st Hospital of Anhui MU,Hefei, Anhui, China, 230022
[4]Peking Union Hospital,Beijing, Beijing, China, 100032
[5]Peking University 1st Hospital,Beijing, Beijing, China, 100034
[6]Xuanwu Hospital,Beijing, Beijing, China, 100053
[7]Beijing Tiantan Hospital,Beijing, Beijing, China, 100070
[8]Beijing Anding Hospital,Beijing, Beijing, China, 100088
[9]Beijing Hospital,Beijing, Beijing, China, 100730
[10]Beijing Hospital,Beijing, Beijing, China, 100730
[11]1st Hospital of Chongqing MU,Chongqing, Chongqing, China, 400016
[12]Fujian Union Hospital,Fuzhou, Fujian, China, 350001
[13]1st Hospital of Fujian MU,Fuzhou, Fujian, China, 350005
[14]Zhongshan Hospital Xiamen U,Xiamen, Fujian, China, 361004
[15]1st Hospital of Guangzhou MU,Guangzhou, Guangdong, China, 510120
[16]Guangzhou 1st People's Hospital,Guangzhou, Guangdong, China, 510180
[17]2nd Hospital of Guangzhou MU,Guangzhou, Guangdong, China, 510260
[18]2nd Hospital Zhongshan University,Guangzhou, Guangdong, China, 510260
[19]2nd Hospital Zhongshan University,Guangzhou, Guangdong, China, 510260
[20]Kangning Hospital of Shenzhen,Shenzhen, Guangdong, China, 518118
[21]1st Hospital of Hebei MU,Shijiazhuang, Hebei, China, 50030
[22]Tangshan Gongren Hospital,Tangshan, Hebei, China, 63000
研究目的：
The purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.
